BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8286639)

  • 1. Invasive aspergillosis in liver transplant recipients: association with candidemia and consumption coagulopathy and failure of prophylaxis with low-dose amphotericin B.
    Singh N; Mieles L; Yu VL; Gayowski T
    Clin Infect Dis; 1993 Nov; 17(5):906-8. PubMed ID: 8286639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis.
    Viviani MA; Tortorano AM; Malaspina C; Colledan M; Paone G; Rossi G; Bordone G; Pagano A
    Eur J Epidemiol; 1992 May; 8(3):433-6. PubMed ID: 1397207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients.
    Fortún J; Martín-Davila P; Moreno S; Barcena R; de Vicente E; Honrubia A; García M; Nuño J; Candela A; Uriarte M; Pintado V
    J Antimicrob Chemother; 2003 Nov; 52(5):813-9. PubMed ID: 14563893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes associated with amphotericin B lipid complex (ABLC) prophylaxis in high-risk liver transplant patients.
    Saliba F; Delvart V; Ichaï P; Kassis N; Botterel F; Mihaila L; Azoulay D; Adam R; Castaing D; Bretagne S; Samuel D
    Med Mycol; 2013 Feb; 51(2):155-63. PubMed ID: 22800082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation.
    Rousey SR; Russler S; Gottlieb M; Ash RC
    Am J Med; 1991 Nov; 91(5):484-92. PubMed ID: 1951410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive aspergillosis in liver transplant recipients in the 1990s.
    Singh N; Arnow PM; Bonham A; Dominguez E; Paterson DL; Pankey GA; Wagener MM; Yu VL
    Transplantation; 1997 Sep; 64(5):716-20. PubMed ID: 9311708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants.
    Minari A; Husni R; Avery RK; Longworth DL; DeCamp M; Bertin M; Schilz R; Smedira N; Haug MT; Mehta A; Gordon SM
    Transpl Infect Dis; 2002 Dec; 4(4):195-200. PubMed ID: 12535262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation.
    Hellinger WC; Bonatti H; Yao JD; Alvarez S; Brumble LM; Keating MR; Mendez JC; Kramer DJ; Dickson RC; Harnois DM; Spivey JR; Hughes CB; Nguyen JH; Steers JL
    Liver Transpl; 2005 Jun; 11(6):656-62. PubMed ID: 15915482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled amphotericin B for prophylaxis against invasive Aspergillus infections.
    Mohammad RA; Klein KC
    Ann Pharmacother; 2006 Dec; 40(12):2148-54. PubMed ID: 17148653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study.
    Tollemar J; Höckerstedt K; Ericzon BG; Jalanko H; Ringdén O
    Transplantation; 1995 Jan; 59(1):45-50. PubMed ID: 7839427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients.
    Conneally E; Cafferkey MT; Daly PA; Keane CT; McCann SR
    Bone Marrow Transplant; 1990 Jun; 5(6):403-6. PubMed ID: 2196098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance and efficacy of Amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patients.
    Erjavec Z; Woolthuis GM; de Vries-Hospers HG; Sluiter WJ; Daenen SM; de Pauw B; Halie MR
    Eur J Clin Microbiol Infect Dis; 1997 May; 16(5):364-8. PubMed ID: 9228476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical analysis of aspergillosis in orthotopic liver transplant recipients].
    Liu ZW; Zou WL; Zhu XD; Zhang XL; Liu Y; Shen ZY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):171-4. PubMed ID: 15760547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients.
    Nieto-Rodriguez JA; Kusne S; Mañez R; Irish W; Linden P; Magnone M; Wing EJ; Fung JJ; Starzl TE
    Ann Surg; 1996 Jan; 223(1):70-6. PubMed ID: 8554421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of invasive fungal infections after liver transplantation and the risk factors of late-onset invasive aspergillosis.
    Nagao M; Fujimoto Y; Yamamoto M; Matsumura Y; Kaido T; Takakura S; Uemoto S; Ichiyama S
    J Infect Chemother; 2016 Feb; 22(2):84-9. PubMed ID: 26683245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation.
    Peghin M; Monforte V; Martin-Gomez MT; Ruiz-Camps I; Berastegui C; Saez B; Riera J; Ussetti P; Solé J; Gavaldá J; Roman A
    Transpl Int; 2016 Jan; 29(1):51-62. PubMed ID: 26339864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation.
    Shi SH; Lu AW; Shen Y; Jia CK; Wang WL; Xie HY; Zhang M; Liang TB; Zheng SS
    Chin Med J (Engl); 2008 Apr; 121(7):625-30. PubMed ID: 18466683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungal infections in patients undergoing bone marrow transplantation: an approach to a rational management protocol.
    Castagnola E; Bucci B; Montinaro E; Viscoli C
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():97-106. PubMed ID: 8932808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study.
    Nguyen MH; Peacock JE; Tanner DC; Morris AJ; Nguyen ML; Snydman DR; Wagener MM; Yu VL
    Arch Intern Med; 1995 Dec 11-25; 155(22):2429-35. PubMed ID: 7503601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for systemic fungal infections in liver transplant recipients.
    Briegel J; Forst H; Spill B; Haas A; Grabein B; Haller M; Kilger E; Jauch KW; Maag K; Ruckdeschel G
    Eur J Clin Microbiol Infect Dis; 1995 May; 14(5):375-82. PubMed ID: 7556225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.